Prevalence of NCD Risk Factors in Kazakhstan

NCT05122832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20400

Last updated 2023-03-14

No results posted yet for this study

Summary

This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.

Conditions

  • Non-Communicable Chronic Diseases

Interventions

DIAGNOSTIC_TEST

Blood test

Glucose Glycosylated hemoglobin Triglycerides Total cholesterol HDL Cholesterol LDL Cholesterol Creatinine COVID-19 Antibody IgM to N protein SARS-Cov-2 (Abbott) COVID-19 Antibody IgG to N protein SARS-Cov-2 (Abbott)

DIAGNOSTIC_TEST

STEPwise Approach to NCD Risk Factor Surveillance (STEPS)

The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids. Through the use of expanded modules, the survey instrument can be expanded to cover a range of topics beyond these risk factors, such as oral health, sexual health and road safety.

DIAGNOSTIC_TEST

Spirometry

Spirometry is a common office test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Principal Investigators

  • Timur M Saliev · S.D. Asfendiyarov Kazakh National Medical University

  • Ildar Fakhradiyev, PhD · S.D. Asfendiyarov Kazakh National Medical University

  • Mukhtar B Kulimbet, MD/MSc · S.D. Asfendiyarov Kazakh National Medical University

  • Zhumaly A Kauyzbay, PhD, AP · Joint Stock Company - South Kazakhstan Medical Academy

  • Samat S Saparbayev, PhD · West Kazakhstan Marat Ospanov Medical University

  • Alma U Nurtazina, MD/PhD · NCJSC Semey Medical University

  • Bayan A Ainabekova, MD/DMSc · NCJSC Astana Medical University

  • Anar A Turmukhambetova, DMSc · NCJSC Karaganda Medical University

  • Maksut K Kulzhanov, DMSc · Kazakhstan's Medical University "KSPH"

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-23
Primary Completion
2022-08-20
Completion
2022-08-20

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05122832 on ClinicalTrials.gov